Akero Therapeutics shares plunge on liver disease treatment’s mixed results
October 10, 2023 at 08:10 AM EDT
Company's lead product candidate shows some benefit for patients with cirrhosis due to fatty liver disease
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|